Heartseed recognized as the "Most Promising Pipelines (iPSC Therapy) Award" at the APAC Cell and Gene Therapy Excellent Awards 2022.
Keiichi Fukuda, CEO at Heartseed is speaking at this year's Cell & Gene Therapy World Asia Summit in September 15-16.
Interview with Keiichi Fukuda was published in "Features", Keio University School of Medicine.
Takehiko Kaneko, CMO at Heartseed, is speaking at this year's webinar by American Physiological Society.
Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's iPSC Manufacturing Summit in July 26-28.
Interview with Takehiko Kaneko, CMO and Head of R&D at Heartseed, was published in RegMedNet.
Heartseed was featured by NHK World's CATCH JAPAN.
An interview with Kikuo Yasui, COO was published in Venture Valuation.
Featured Story on Heartseed was listed on Science Japan by Japan Science and Technology Agency (JST)."Developing a next-generation therapy for severe heart failure using iPS cells"
Heartseed named "Ministry of Education, Culture, Sports, Science and Technology (MEXT) Award" at Academic Startups 2021